Kristin Technau-Hafsi Selected Research

Kristin Technau-Hafsi Research Topics

3	Inflammation (Inflammations) 10/2023 - 01/2018
3	Melanoma (Melanoma, Malignant) 01/2021 - 06/2017
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2024 - 06/2023
2	Neoplasms (Cancer) 01/2024 - 01/2018
2	Skin Manifestations 10/2023 - 01/2021
2	Epidermolysis Bullosa Dystrophica (Dystrophic Epidermolysis Bullosa) 06/2023 - 04/2023
2	Psoriasis (Pustulosis Palmaris et Plantaris) 06/2023 - 01/2022
2	Esophageal Stenosis (Esophageal Stricture) 10/2019 - 12/2016
2	Argyria 10/2015 - 10/2015
1	Epidermolysis Bullosa 01/2024
1	Porokeratosis (Palmoplantar Porokeratosis) 10/2023
1	Carcinoma (Carcinomatosis) 06/2023
1	Disease Progression 06/2023
1	Eczema 06/2023
1	Darier Disease (Darier's Disease) 04/2023
1	Benign Familial Pemphigus (Hailey Hailey Disease) 04/2023
1	Ichthyosis (Xeroderma) 04/2023
1	Lamellar Ichthyosis (Harlequin Ichthyosis) 04/2023
1	Infections 01/2022
1	Psoriatic Arthritis 01/2022
1	Incontinentia Pigmenti (Bloch Sulzberger Syndrome) 01/2022
1	Rosacea (Acne Rosacea) 02/2020
1	Cicatrix (Scar) 12/2016
1	Pathologic Constriction (Stenosis) 12/2016
1	Chronic Kidney Failure (Chronic Renal Failure) 04/2016
1	Hyperparathyroidism 04/2016
1	Edema (Dropsy) 04/2016
1	Calciphylaxis 04/2016
1	Urticaria (Hives) 03/2016
1	Pemphigus (Pemphigus Vulgaris) 03/2014
1	Linear IgA Bullous Dermatosis 03/2014
1	Ulcerative Colitis 03/2014

2	EnzymesIBA 01/2024 - 01/2018
2	CytokinesIBA 10/2023 - 01/2022
2	Interleukin-17 (Interleukin 17)IBA 10/2023 - 04/2023
2	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 06/2023 - 01/2018
2	Biomarkers (Surrogate Marker)IBA 06/2023 - 06/2023
2	Budesonide (Pulmicort)FDA LinkGeneric 10/2019 - 12/2016
2	SolutionsIBA 10/2015 - 10/2015
2	SilverIBA 10/2015 - 10/2015
2	colloidal silverIBA 10/2015 - 10/2015
1	Immune Checkpoint ProteinsIBA 01/2024
1	Interleukin-5 (Interleukin 5)IBA 10/2023
1	RNA (Ribonucleic Acid)IBA 10/2023
1	Apoptosis Regulatory ProteinsIBA 06/2023
1	LigandsIBA 06/2023
1	InterleukinsIBA 04/2023
1	Keratin-2 (Keratin 2)IBA 04/2023
1	Interleukin-12 (IL 12)IBA 01/2022
1	Adalimumab (Humira)FDA Link 01/2022
1	amsonic acid (DAS)IBA 01/2022
1	Tumor Biomarkers (Tumor Markers)IBA 01/2021
1	AntibodiesIBA 01/2018
1	BiglycanIBA 06/2017
1	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2016
1	TOR Serine-Threonine KinasesIBA 04/2016
1	Omalizumab (Xolair)FDA Link 03/2016
1	Immunoglobulin A (IgA)IBA 03/2014